2023-12-01 06:28:19 ET
- Glucotrack ( NASDAQ: GCTK ) has received a notification letter from Nasdaq Stock market LLC that the Company has been granted an additional 180-day compliance period, or until May 20, 2024, to regain compliance with Nasdaq’s minimum bid price rule.
- The company received letter from Nasdaq on May 26, 2023 stating that the company is non-compliance to its minimum bid price requirements as the company is trading below $1.00 for the previous 30 consecutive business days.
- The company received another letter in November stating that the Nasdaq has granted additional 180 calendar day period to regain compliance
- GCTK +7% premarket to $0.2515
- Source: Press Release
For further details see:
Nasdaq grants additional 180 days to Glucotrack to regain compliance